If you purchased any of the below products between 2011 and December 2024, please register your details with us.
RegisterIf you purchased any of the above products between 2011 to December 2024, please register your details with us by visiting the registration page via the below link.
On 20 December 2024 class action proceedings were commenced in the Federal Court of Australia against Johnson & Johnson Pacific Pty Ltd (Johnson & Johnson) alleging that Johnson & Johnson manufactured and distributed oral cold and flu products containing Phenylephrine under the Codral, Sudafed and Benadryl brands that are ineffective at relieving the symptoms of cold and flu they were marketed to treat.
Group members in this class action are persons who purchased any of the below products between 2011 to December 2024. If this includes you, please register your details with us by visiting the registration page via the below link.
Benadryl Mucus Relief Plus Decongestant
Benadryl PE Chesty Cough & Nasal Congestion
Benadryl PE Dry Cough & Nasal Congestion
Codral Cold & Flu
Codral Cold & Flu (Reformulation 2)
Codral Cold & Flu + Dry Cough
Codral Cold & Flu + Mucus Cough
Codral Cold & Flu + Mucus Cough (powder sachet)
Codral Cold & Flu (powder sachet)
Codral Day & Night
Codral Day & Night + Dry Cough
Codral Day & Night New Formula
Codral Decongestant
Codral Dry Cough + Cold (liquid medicine)
Codral Mucus Cough + Cold (liquid medicine)
Codral Multi Action
Codral Night
Codral Plus
Codral Plus Mucus + Cold & Flu
Codral Relief Cold & Flu + Decongestant
Sinutab PE Sinus, Allergy & Pain Relief
Sudafed PE Nasal Decongestant
Sudafed PE Night
Sudafed PE Sinus + Allergy & Pain Relief
Sudafed PE Sinus + Anti inflammatory Pain Relief
Sudafed PE Sinus + Pain Relief
Sudafed PE Sinus + Pain Relief Day + Night
JGA Saddler is committed to ensuring that everyone, regardless of their background or financial situation, has access to justice. We run our class actions in a way that means you are not exposed to any costs or financial risk, so joining a class action will cost you nothing.
The class action is being funded by Omni Bridgeway on a “no win, no pay” basis in accordance with the terms of a funding agreement or terms imposed by the Court. If the class action is successfully resolved and there is a recovery of compensation, Omni Bridgeway will be entitled to reimbursement of the costs of the class action that it has funded plus a commission from the judgment or settlement amount, pursuant to the terms of the funding agreement.
Further, group members do not have to pay anything if the class action is unsuccessful, as Omni Bridgeway agrees to pay any legal costs that might be awarded to Johnson & Johnson.
No. Group members do not have to pay anything in the event that the class action is unsuccessful, as Omni Bridgeway agrees to pay any legal costs that might be awarded to Johnson & Johnson.
Unfortunately, we are unable to provide a timeframe of how long the class action will take to resolve. Our objective will always be to act in the best interests of the group to ensure any resolution is reached as quickly as possible while ensuring the best outcome for group members.
A class action is a group proceeding comprised of seven or more people who have been wronged by an individual or corporation. These claims generally arise out of similar circumstances that allow the group an opportunity to be heard based on common issues of law or fact. These proceedings are often commenced by one lead litigant on behalf of the group.